Morena D’Alise

Morena D’Alise

Company: Nouscom

Job title: Head of Preclinical & Clinical Immunology


How do Viral Vectored Vaccines Targeting Tumour Neoantigens Elicit Potent & Effective Anti-tumour Immune Response? 9:30 am

Developing a potent heterologous prime/boost immunisation approach based on viral vectors (non-human Great Ape Adenovirus and MVA) encoding an unprecedented number of tumour neoantigens Demonstrating induction of strong and high-quality T cell immune response in patients Interrogating the intra-tumoural TCR repertoire to dissect the contribution of vaccine-induced T cells to clinical responsesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.